Skip to main content

Chloroprocaine ophthalmic Pregnancy and Breastfeeding Warnings

Brand names: Iheezo

Medically reviewed by Drugs.com. Last updated on Oct 23, 2023.

Chloroprocaine ophthalmic Pregnancy Warnings

The manufacturer makes no recommendation regarding use during pregnancy.

US FDA pregnancy category: Not assigned.

Risk summary: No data available on use of this drug in pregnant women to inform a drug-related risk.

Animal studies have not been reported. There are no controlled data in human pregnancy.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

See references

Chloroprocaine ophthalmic Breastfeeding Warnings

Safety has not been established. Benefit should outweigh risk.

Excreted into human milk: Data not available
Excreted into animal milk: Data not available

See references

See also

References for pregnancy information

  1. Product Information. Iheezo (chloroprocaine ophthalmic). Harrow Eye, LLC. 2022;1.

References for breastfeeding information

  1. Product Information. Iheezo (chloroprocaine ophthalmic). Harrow Eye, LLC. 2022;1.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer